In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 237.2 | 201.3 | 193.1 | 197.0 | 176.2 | 151.6 | 117.7 | 93.2 |
Interest income on investments | 11.5 | 6.3 | 8.5 | 12.1 | 177.5 | 152.8 | 118.2 | 94.9 |
| 252.2 | 209.7 | 203.9 | 214.1 | 190.5 | 163.0 | 126.6 | 102.0 |
Interest expense: |
| 33.9 | 21.3 | 29.6 | 44.9 | 32.4 | 19.8 | 12.4 | 8.1 |
Net interest income | 218.3 | 188.4 | 174.4 | 169.2 | 158.1 | 143.2 | 114.2 | 93.9 |
Provision for loan losses | 12.2 | -10.1 | 40.8 | 8.5 | 20.3 | 9.9 | 4.8 | 3.8 |
Net interest income after provision for loan losses | 206.1 | 198.5 | 133.6 | 160.7 | 137.8 | 133.3 | 109.4 | 90.1 |
Deposit and loan fees | | | | | | | | 4.2 |
Gain on sale of investments, net | | | | | | | | 1.3 |
Other non-interest income | 77.9 | 83.2 | 78.3 | 65.4 | 60.2 | 59.2 | 56.0 | 46.9 |
Total non-interest income | 77.9 | 83.2 | 78.3 | 65.4 | 60.2 | 59.2 | 56.0 | 52.4 |
Non-interest expenses | 186.8 | 167.4 | 155.0 | 146.1 | 137.2 | 130.7 | 142.0 | 105.5 |
Pre-tax income before non-recurring items | 97.4 | 114.3 | 58.3 | 80.1 | 61.3 | 61.8 | 41.0 | 41.2 |
Non-recurring items | 0.2 | | 1.4 | | 0.6 | | 17.7 | 4.2 |
Pre-tax income | 97.2 | 114.3 | 56.9 | 80.1 | 60.7 | 61.8 | 23.4 | 37.0 |
Income taxes | 19.1 | 22.5 | 10.0 | 14.3 | 10.1 | 17.7 | 3.9 | 9.8 |
Tax rate | 19.6% | 19.7% | 17.5% | 17.9% | 16.7% | 28.7% | 16.6% | 26.4% |
Net income | 78.1 | 91.8 | 46.9 | 65.7 | 50.5 | 44.1 | 19.5 | 27.3 |
Net margin | 27.5% | 32.6% | 22.1% | 29.1% | 25.5% | 22.9% | 11.8% | 19.1% |
|
Basic EPS | $2.66 | $3.12 | $1.61 | $2.25 | $1.73 | $1.66 | $0.85 | $1.40 |
Diluted EPS | $2.64 | $3.11 | $1.60 | $2.25 | $1.73 | $1.65 | $0.85 | $1.40 |
|
Shares outstanding (basic) | 29.4 | 29.4 | 29.2 | 29.2 | 29.2 | 26.6 | 22.9 | 19.5 |
Shares outstanding (diluted) | 29.6 | 29.6 | 29.3 | 29.3 | 29.3 | 26.7 | 22.9 | 19.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |